Covaxin can help control virus load, reduce disease severity: Study

Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and its variants of concern that persists for at least six months after vaccination and induces memory T cells that can respond robustly against the variants. Jul 16, 2022